Advances in Understanding the Nature and Features of Misophonia
This first peer-reviewed collection on misophonia explores the condition’s defining features, triggers, and emerging research into its causes.
Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
This first peer-reviewed collection on misophonia explores the condition’s defining features, triggers, and emerging research into its causes.
Pediatric brain cancer is the leading cause of cancer death in children. SPARC’s Giving Smarter Guide outlines key opportunities for philanthropy to strengthen research infrastructure and transform care for young patients.
Brain cancer is the leading cause of cancer death in children and teens. A transformative philanthropic gift is now reshaping the field by supporting new therapies, patient care, and collaborative research.
The Milken Institute Center for Strategic Philanthropy celebrates a $96 million gift to Children’s National Hospital supporting research, innovation, and family care for children with brain cancer.
Children’s National Hospital has received a $96 million donation from an anonymous donor family. The hospital will use it to advance brain tumor research in children.
Awareness of mental health has grown rapidly, yet conditions like bipolar disorder remain poorly understood and difficult to treat. BD² is working to uncover the genetic and biological factors behind these illnesses.
Rare diseases impact millions of people around the world, yet treatments remain limited and progress is slow. This article explores how philanthropy is helping drive breakthroughs, build collaborations, and create models that could reshape the entire medical research ecosystem.
Precision medicine is transforming health care, but uneven representation in genetic research limits its reach and equity. This session explores how global collaboration, inclusive infrastructure, and philanthropic investment can ensure that precision medicine benefits all populations.
The Baszucki Brain Research Fund and the Milken Institute announced the annual recipients of the 2022 Metabolic Mind Awards, which reward clinicians for their work in advancing Ketogenic Metabolic Therapy for mental disorders. 
Type 1 diabetes has no cure, but early screening can improve outcomes. Supported by the Helmsley Charitable Trust, this SPARC report outlines a roadmap to implement widespread T1D autoantibody screening.
SPARC released an updated road map for implementing T1D autoantibody screening, highlighting progress, ongoing challenges, and opportunities for collaboration to expand screening in the general population.